Company intelligence / Profile preview

Bora Biologics

Ownership: Private
Employees: ~125
Development stage: Commercial

Overview

Bora Biologics has developed over 45 biologic products—including more than 15 biosimilars—and has successfully delivered over 100 cGMP batches. The company operates FDA registered facilities in San Diego (US) and Zhubei City (Taiwan), supporting clinical through commercial-scale production. It boasts one commercially approved biosimilar in the US/Canada.

Modalities: Monoclonal antibodyBiosimilarProteinRecombinant protein
Industry: Contract Manufacturing Organization

Partnerships

Bora PharmaceuticalsMultiple biopharma clients globally

Beyond the preview

Go deeper on Bora Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bora Biologics.

Explore the full profile